Floatz logo

Therapeutic Asset Ratings

18,153 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Capecitabine
Head And Neck Squamous Cell Carcinoma
Merck Sharp & Dohme LLCP2BB (67)
Carboplatin
Malignant Pleural Mesothelioma
AstraZenecaP2BB (67)
Carboplatin
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer InstituteP2BB (67)
Carboplatin
Anaplastic Astrocytoma
Oliver JonasP2BB (67)
Carboplatin
Anaplastic Oligodendroglioma
Oliver JonasP2BB (67)
Carboplatin
Hereditary Breast Ovarian Cancer Syndrome
VA Office of Research and DevelopmentP2BB (67)
Carboplatin
Bladder Transitional Cell Carcinoma
Jonsson Comprehensive Cancer CenterP2BB (67)
Carboplatin
Hypogonadism
University of WashingtonP2BB (67)
Carboplatin
Minimally Invasive Lung Adenocarcinoma
NRG OncologyP2BB (67)
Carboplatin
Prostate Small Cell Carcinoma
M.D. Anderson Cancer CenterP2BB (67)
Carboplatin
Primary Mediastinal Large B-Cell Lymphoma
David Bond, MDP2BB (67)
Carboplatin
Sarcoma
OHSU Knight Cancer InstituteP2BB (67)
Cis-Diamminedichloroplatinum Ii
Sarcoma
Roswell Park Cancer InstituteP2BB (67)
Cladribine
Acute Biphenotypic Leukemia
University of WashingtonP2BB (67)
Cyclophosphamide
Amyloidosis
University of Alabama at BirminghamP2BB (67)
Cyclophosphamide
Gliosarcoma
Mayo ClinicP2BB (67)
Cyclophosphamide
Immune System Disorder
Indapta Therapeutics, INC.P2BB (67)
Cyclophosphamide
Malignant Mesothelioma
M.D. Anderson Cancer CenterP2BB (67)
Cyclophosphamide
Neuroblastoma
Robbie MajznerP2BB (67)
Cyclophosphamide
Plasmablastic Lymphoma
National Cancer Institute (NCI)P2BB (67)
Cyclophosphamide
Ovarian Carcinoma
Beijing BiotechP2BB (67)
Cyclophosphamide
Soft Tissue Sarcoma
St. Jude Children's Research HospitalP2BB (67)
Decitabine
Myeloproliferative Neoplasm
Jacqueline Garcia, MDP2BB (67)
Dexasone
High Grade B-Cell Lymphoma
University of California, DavisP2BB (67)
Dexasone
Hematologic Disorder
Hellenic Society of HematologyP2BB (67)
Showing 2201 to 2225 of 18,153 assets
PreviousPage 89 of 727Next